EUVIMEDEUVIMED entdecken
Crossref

Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes

Julian W Sacre iD, Kristin Lundegard, Kamel Mohammedi iD, Bendix Carstensen, Hertzel C Gerstein iD, Jonathan E Shaw

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Julian W Sacre und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Heart Failure, Diabetic Angiopathies, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Sanofi, State Government of Victoria, Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Heart failure (HF) may develop in type 2 diabetes without prior cardiovascular disease (CVD). This study aimed to identify risk factors that distinguish CVD that presents first as a HF event versus CVD that presents first as an atherosclerotic event (ASCVD), among people with type 2 diabetes. Materials and methods ORIGIN and REWIND trial participants with type 2 diabetes but free of CVD ( N = 6175; 64 ± 7 years, 50.1% female) were followed for ~5.8 years for incident CVD presenting first as either a HF event (HF hospitalization or HF death), ASCVD (myocardial infarction, unstable angina, stroke, or revascularization), or other cardiovascular death. Multi‐state models characterised event‐specific associations of risk factors with each possible first CVD event.

Results

HF was the first event in 16.8% of 1024 incident CVD cases. Older age, higher BMI, and higher urine albumin:creatinine ratio were more strongly associated with CVD manifesting first as HF, rather than as ASCVD or other cardiovascular death. ASCVD as the first event (65.2% of cases) was more strongly associated with worse LDL‐cholesterol and HbA1c. These unique associations of risk factors with HF versus ASCVD translated to variable probabilities of HF as the first CVD event, depending on the clinical profile (32.0% for a profile enriched with HF‐specific risk factors versus 5.1% for a profile enriched with ASCVD‐specific risk factors).

Conclusions

CVD that presents first as a HF event is common in type 2 diabetes and its risk factors are distinct from those associated with CVD that presents first as an ASCVD event.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Heart FailureDiabetic AngiopathiesCardiovascular DiseasesDiabetic CardiomyopathiesHumansFemaleMiddle AgedMaleRisk FactorsAgedIncidenceGlycated HemoglobinAtherosclerosisHeart Disease Risk Factors

Stichwörter der Autor:innen

cardiovascular diseasediabetes complicationsheart failuremacrovascular diseasetype 2 diabetes

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • INSERM Unit 1034, Biology of Cardiovascular Diseases, Bordeaux University Hospital, Bordeaux, France.
  • Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

ORCID-Profile: Julian W Sacre, Kamel Mohammedi, Hertzel C Gerstein

Förderung

  • Sanofi
  • State Government of Victoria
  • Eli Lilly and Company
  • National Health and Medical Research Council

Zitieren

APA

Sacre, J. W., Lundegard, K., Mohammedi, K., Carstensen, B., Gerstein, H. C., & Shaw, J. E. (2026). Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70426

Vancouver

Sacre JW, Lundegard K, Mohammedi K, Carstensen B, Gerstein HC, Shaw JE. Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70426

BibTeX
@article{Sacre2026,
  author = {Sacre, Julian W and Lundegard, Kristin and Mohammedi, Kamel and Carstensen, Bendix and Gerstein, Hertzel C and Shaw, Jonathan E},
  title = {Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70426}
}
Kostenlos starten →